EPC III: Genomic Testing for Risk of Recurrent Cancer
UNC personnel at the RTI-UNC Evidence-based Practice Center (EPC) will collaborate with investigators at RTI to: 1) conduct a systematic review of available literature for evidence that testing of molecular markers of the risk of tumor recurrence, used separately or in combination with ‘standard’ indicators of risk recurrence, improves predictions of tumor recurrence and leads to changes in physician decisions about patient treatment and to improved patient outcomes, and 2) produce an organized report of the findings of the systematic review, that presents available evidence for the identified key questions.
Principal Investigator: Timothy S Carey, MD, MPH/Daniel Jonas, PhD
Funding: AHRQ via RTI
Total Project Period: 10/25/12-01/13/14